Related Experiment Videos
Anticonvulsant drugs, growth, and development
Archives of Disease in Childhood
|June 1, 1987
Summary
Anticonvulsant drugs did not significantly affect growth in children with epilepsy. This study monitored height and puberty stages in 67 children during up to five years of treatment.
Area of Science:
- Pediatric Neurology
- Endocrinology
- Pharmacology
Background:
- Epilepsy is a common neurological disorder in children.
- Anticonvulsant drugs are standard treatments for epilepsy.
- Potential side effects of long-term medication on child development require investigation.
Purpose of the Study:
- To assess the impact of anticonvulsant medications on the growth and pubertal development of children with epilepsy.
- To monitor drug concentrations and correlate them with growth parameters.
Main Methods:
- Longitudinal study of 67 children diagnosed with epilepsy.
- Measurement of height and pubertal stage before treatment and annually for up to five years.
- Monitoring of blood concentrations for phenytoin, sodium valproate, carbamazepine, ethosuximide, and phenobarbitone.
Main Results:
- No statistically significant deviations in height or pubertal development patterns were observed during the treatment period.
- Drug concentrations remained within therapeutic ranges for most participants.
Conclusions:
- Commonly prescribed anticonvulsant medications appear to have a neutral effect on growth and puberty in children with epilepsy.
- Continued monitoring ensures therapeutic drug levels without compromising physical development.